Medicalbiologicallaboratory as an object of modeling

by O V Igumnova, E A Lukyanova, V D Protsenko, E M Shimkevich
Published 2011-06-01

New methods of laboratory training performance

by O V Igumnova, E M Shimkevich, D A Ananuin, C B Gordon, E A Lukyanova, V D Protsenko
Published 2010-06-01

The main results of clinical trials of the efficacy, safety and pharmacokinetics of the perspective anti-tuberculosis drug makozinone (PBTZ169)

by A. O. Mariandyshev, A. L. Khokhlov, S. V. Smerdin, V. S. Shcherbakova, O. V. Igumnova, I. V. Ozerova, A. A. Bolgarina, N. A. Nikitina
Published 2020-03-01

Effect of physicochemical properties on the pharmacokinetic parameters of the new representative of benzothiazinones antituberculosis drug macozinonе

by A. L. Khokhlov, A. O. Mariandyshev, V. S. Shcherbakova, I. V. Ozerova, Yu. G. Kazaishvili, O. V. Igumnova, A. A. Bolgarina, B. A. Rudoy
Published 2020-12-01

CRISPR-Cas Loci of Yersinia pseudotuberculosis Strains with Different Genetic Determinants

by N. P. Peretolchina, V. T. Klimov, E. A. Voskresenskaya, G. I. Kokorina, E. A. Bogumilchik, A. L. Trukhachev, S. V. Igumnova, Y. P. Dzhioev, V. I. Zlobin
Published 2020-05-01

The production of hyperimmune pseudotuberculosis sera

by T. Yu. Zagoskina, E. Yu. Markov, N. M. Аndreevskaya, V. T. Klimov, V. B. Nikolaev, A. V. Ulanskaya, A. V. Kryukova, S. V. Igumnova, T. M. Dolgova, V. Yu. Kolesnikova, M. V. Chesnokova, O. V. Gavrilova, S. V. Balakhonov
Published 2021-08-01